Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 198

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

The new era of nanotechnology, an alternative to change cancer treatment

Open access
Jurj, Ancuta, Braicu, Cornelia, Pop, Laura-Ancuta, Tomuleasa, Ciprian, Gherman, Claudia, Berindan-Neagoe, Ioana · 2017 · Drug Design, Development and Therapy

Abstract

In the last few years, nanostructures have gained considerable interest for the safe delivery of therapeutic agents. Several therapeutic approaches have been reported, such as molecular diagnosis, disease detection, nanoscale immunotherapy and anticancer drug delivery that could be integrated into clinical use. The current paper aims to highlight the background that supports the use of nanoparticles conjugated with different types of therapeutic agents, applicable in targeted therapy and cancer research, with a special emphasis on hematological malignancies. A particular key point is the functional characterization of nonviral delivery systems, such as gold nanoparticles, liposomes and dendrimers. The paper also presents relevant published data related to microRNA and RNA interference delivery using nanoparticles in cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/dddt.s142337

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 198

Metadata

Authors
Jurj, A., Braicu, C., Pop, L.-A., Tomuleasa, C., Gherman, C., & Berindan-Neagoe, I.
Venue
Drug Design, Development and Therapy
Published
2017-09
Volume
Volume 11
Pages
2871-2890
ISSN
1177-8881 (ISSN-L)
OpenAlex
W2758273859
Cited by
198
References
7
FWCI
6.01
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The new era of nanotechnology, an alternative to change cancer treatment. https://app.cochat.ai/papers/10.2147/dddt.s142337
The paper
Jurj, A., Braicu, C., Pop, L.-A., Tomuleasa, C., Gherman, C., & Berindan-Neagoe, I. (2017). The new era of nanotechnology, an alternative to change cancer treatment. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s142337

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.